Are all beta-lactams similarly effective in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia?  M. Paul, N. Zemer-Wassercug, O.

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Benchmarking inappropriate empirical antibiotic treatment
G. Cornaglia, A. Lönnroth, M. Struelens 
Gut bacterial microbiota and obesity
M.F.Q. Kluytmans-VandenBergh, J.A.J.W. Kluytmans 
Approach to diagnosis of infective endocarditis
Incidence and outcome of Staphylococcus aureus endocarditis—a 10-year single-centre northern European experience  H. Asgeirsson, A. Thalme, M. Kristjansson,
Molecular characterization of methicillin-resistant Staphylococcus aureus isolated over a 2-year period in a Qatari hospital from multinational patients 
S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler 
Association of vancomycin serum concentrations with efficacy in patients with MRSA infections: a systematic review and meta-analysis  T. Steinmetz, N.
Nosocomial infection caused by class 1 integron-carrying Staphylococcus aureus in a hospital in South China  Z. Xu, L. Shi, C. Zhang, L. Zhang, X. Li,
The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram- positive bacteria  M.J. Rybak  Clinical Microbiology and Infection 
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
E. Lindberg, I. Adlerberth, A.E. Wold 
Clinical impact of antibiotic-resistant Gram-positive pathogens
Cost-effectiveness of universal MRSA screening on admission to surgery
R. Cantón  Clinical Microbiology and Infection 
Louis Pasteur, from crystals of life to vaccination
J.-P. Stahl  Clinical Microbiology and Infection 
Use of surveillance cultures and enteral vancomycin to control methicillin-resistant Staphylococcus aureus in a paediatric intensive care unit  K. Thorburn,
E. Braun, K. Hussein, Y. Geffen, G. Rabino, Y. Bar-Lavie, M. Paul 
W. Witte, B. Pasemann, C. Cuny  Clinical Microbiology and Infection 
Nosocomial infection caused by class 1 integron-carrying Staphylococcus aureus in a hospital in South China  Z. Xu, L. Shi, C. Zhang, L. Zhang, X. Li,
Vector control: a cornerstone in the malaria elimination campaign
Rapid genotyping of methicillin-resistant Staphylococcus aureus (MRSA) isolates using miniaturised oligonucleotide arrays  S. Monecke, R. Ehricht  Clinical.
A new multiplex PCR for easy screening of methicillin-resistant Staphylococcus aureus SCCmec types I–V  K. Boye, M.D. Bartels, I.S. Andersen, J.A. Møller,
G. Höffken  Clinical Microbiology and Infection 
Low prevalence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in Belgian hospitals  C. Nonhoff, O. Denis,
A variant of the Southern German clone of methicillin-resistant Staphylococcus aureus is predominant in Croatia  A. Budimir, R.H. Deurenberg, Z. Bošnjak,
Bacterial resistance—the clinical challenge
Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia  M. Bassetti, E.M. Trecarichi, A. Mesini,
Evaluation of vancomycin MIC creep in methicillin-resistant Staphylococcus aureus infections—a systematic review and meta-analysis  R. Diaz, V. Afreixo,
Levofloxacin in the treatment of ventilator-associated pneumonia
R. Bitterman, M. Paul, D. Polak, Y. Geffen 
Metagenomics and probiotics
M. Aires-de-Sousa  Clinical Microbiology and Infection 
Systematic review of antibiotic consumption in acute care hospitals
Antibacterial drug discovery in the 21st century
A.W. Karchmer  Clinical Microbiology and Infection 
Benchmarking inappropriate empirical antibiotic treatment
P.M. Hawkey  Clinical Microbiology and Infection 
Current experience in treating invasive zygomycosis with posaconazole
Community-associated Staphylococcus aureus infections and nasal carriage among children: molecular microbial data and clinical characteristics  G. Sdougkos,
Sequential time to positivity of blood cultures can be a predictor of prognosis of patients with persistent Staphylococcus aureus bacteraemia  M.-S. Hsu,
G.M. Rossolini, E. Mantengoli  Clinical Microbiology and Infection 
Statin use and clinical outcomes among pneumonia patients
P. Kaltsas, S. Want, J. Cohen  Clinical Microbiology and Infection 
J.-M. Rolain, C. Abat, P. Brouqui, D. Raoult 
W. Eugene Sanders, Christine C. Sanders 
Predictors of clinical and microbiological treatment failure in patients with methicillin- resistant Staphylococcus aureus (MRSA) bacteraemia: a retrospective.
Rise and subsequent decline of community-associated methicillin resistant Staphylococcus aureus ST30-IVc in Copenhagen, Denmark through an effective search.
S. Tom, J. C. Galbraith, L. Valiquette, G. Jacobsson, P. Collignon, H
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
E. Tacconelli  Clinical Microbiology and Infection 
Panton–Valentine leukocidin-encoding bacteriophage and gene sequence variation in community-associated methicillin-resistant Staphylococcus aureus  J.A.
Modelling during an emergency: the 2009 H1N1 influenza pandemic
J. Wilson, S. Elgohari, D. M. Livermore, B. Cookson, A. Johnson, T
A. Manzur, F. Gudiol  Clinical Microbiology and Infection 
O. Megged, A.M. Yinnon, D. Raveh, B. Rudensky, Y. Schlesinger 
B.A. Cunha  Clinical Microbiology and Infection 
The economic value of screening haemodialysis patients for methicillin-resistant Staphylococcus aureus in the USA  B.Y. Lee, Y. Song, S.M. McGlone, R.R.
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
Impact of source of infection and vancomycin AUC0–24/MICBMD targets on treatment failure in patients with methicillin-resistant Staphylococcus aureus.
D.A. Robinson, M.C. Enright  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
J. Segreti  Clinical Microbiology and Infection 
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Presentation transcript:

Are all beta-lactams similarly effective in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia?  M. Paul, N. Zemer-Wassercug, O. Talker, Y. Lishtzinsky, B. Lev, Z. Samra, L. Leibovici, J. Bishara  Clinical Microbiology and Infection  Volume 17, Issue 10, Pages 1581-1586 (October 2011) DOI: 10.1111/j.1469-0691.2010.03425.x Copyright © 2011 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 1 Patient selection. 1Vancomycin was administered empirically together with the beta-lactam in 9/131 (6.9%) patients in group 1; 0% in group 2; 23/194 (11.9%) in group 3; 16/61 (26.2%) in group 4 and 34/57 (59.6%) patients in group 5. Clinical Microbiology and Infection 2011 17, 1581-1586DOI: (10.1111/j.1469-0691.2010.03425.x) Copyright © 2011 European Society of Clinical Infectious Diseases Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.